Antiepileptic activity of delta sleep-inducing peptide and its analogue in metaphit-provoked seizures in rats  by Stanojlović, Olivera P. et al.
Sf
1
deizure (2005) 14, 240—247
www.elsevier.com/locate/yseizAntiepileptic activity of delta sleep-inducing
peptide and its analogue in metaphit-provoked
seizures in ratsOlivera P. Stanojlovic´ a,*, Dragana P. Zˇivanovic´ a,
Slobodan D. Mirkovic´ a, Inessa I. Mikhaleva baDepartment of Physiology, School of Medicine, University of Belgrade, 11000 Belgrade,
Visˇegradska 26/II, Serbia
b Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, RussiaKEYWORDS
Metaphit;
Audiogenic epilepsy;
Delta sleep-inducing
peptide;
Analogue;
EEG;
Power spectra* Corresponding author. Tel.: +381 11
ax: +381 11 3611945.
E-mail address: maxol@eunet.yu (O
059-1311/$ — see front matter # 200
oi:10.1016/j.seizure.2005.02.001Summary
Problem: Previous studies have shown that humoral, endogenous and somnogenic,
delta sleep-inducing peptide (DSIP) has influence on insomnia, pain, adaptation to
stress, epilepsy, etc. We investigated the potential of DSIP and its analogue DSIP12 (a
nonapeptide with alanine in position 2 of DSIP molecule substituted by b-alanine) to
antagonize metaphit (1-[1(3-isothiocyanatophenyl)-cyclohexyl]piperidine) induced
generalized, reflex audiogenic seizures in adult male Wistar albino rats.
Methods: The rats divided in four groups received (i.p.): saline; metaphit; meta-
phit + DSIP; and metaphit + DSIP12, respectively. Metaphit-treated animals display-
ing seizure in eight previous tests received DSIP or DSIP12 and afterwards audiogenic
stimuli were applied at hourly intervals for the next 30 h. The animals were exposed to
sound stimulation 60 min after metaphit administration and further on at hourly
intervals. Incidence and severity of seizures were behaviorally analyzed. Selected
EEGs and power spectra were recorded and analyzed.
Results and conclusions: Metaphit led to hypersynchronous epileptiform activity
(polyspikes and spike-wave complexes) and increased power spectra 0.5—30 h after
the treatment. Severity of metaphit seizures increased with time to reach the peak
7—12 h after injection. DSIP and DSIP12 significantly (
*P < 0.05 and **P < 0.01)
increased in d and u frequency bands and decreased the incidence, mean seizure
grade and duration of metaphit convulsions. The results suggest that DSIP and DSIP12
may be considered as potential antiepileptics in the animalmodel, DSIP12 beingmore
efficient than DSIP.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.3611945;
.P. Stanojlovic´).
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Audiogenic seizures, representing a generalized
form of the reflex epilepsy, express typical signsby Elsevier Ltd. All rights reserved.
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Figure 1 The evolution of EEG changes in one particular metaphit-treated animal (10 mg/kg, i.p.). Spiking of large
amplitude and high frequency and their progression into multiple spikes (upper tracings). Power spectra of the
corresponding EEG activity started to increase (bottom). Numbers in the lower parts of the figure refer to the absolute
power (mV2) of the d, u, a, b1, b2, bands and of the total (Tot) spectra. LFO: left frontooccipital cortex.
Figure 2 Examples of EEG recording and power spectra following metaphit administration with behavioral seizure
grade 3. A high amplitude, low frequency synchronized spiking activity (1—4 Hz) was not terminated with sound offset.
Power spectra started to increase with fast tendency in the course of metaphit epilepsy. For the details see caption to
Fig. 1. RP-LO: right parietal-left occipital cortex.
242 O.P. Stanojlovic´ et al.of epilepsy–—running, clonus and tonus. Experimen-
tal metaphit (1-[1(3-isothiocyanatophenyl)-cyclo-
hexyl]piperidine) model of seizures is suitable for
the studies of audiogenic epilepsy and preclinical
evaluation of potential avenues in antiepileptic
treatment.1,2 Metaphit, a phencyclidine (PCP) ana-
logue different in an isothiocyanate group in m-
position of the aromatic ring, irreversibly binds to
the ionic channel of the N-methyl-D-aspartic acid/
phencyclidine (NMDA/PCP) receptor complex.3
Metaphit was shown to increase general brain excit-
ability and to induce audiogenic seizures in small
rodents.4,5
Upon the discovery of the delta sleep-inducing
factor (DSIP) in human fluids,6,7 numerous authorsTable 1 Time course of metaphit-induced seizure compon
T (h) Running Clonus
n = 12
(mp)
n = 9
(D)
n = 9
(A)
n = 12
(mp)
1 2 1
2 3 2
3 4 3
4 4 4
5 9 7
6 8 8
7 9 9
8 9 9 9 9
9 9 9 6 9
10 10 9 5a,* 10
11 9 9 5a,* 9
12 9 8 6 8
13 8 8 3 6
14 7 7 4 7
15 8 6 4 5
16 6 7 4 6
17 5 7 3 5
18 4 5 4 4
19 5 3 2 5
20 5 2 1 4
21 3 2 1 2
22 3 1 1 3
23 4 0 0 3
24 4 0 0 4
25 5 0b,* 0c,* 4
26 3 0 0 3
27 2 2
28 2 2
29 3 3
30 1 1
n: number of animals; T: time after metaphit administration; mp: m
metaphit (10 mg/kg) followed 8 h later by DSIP (0.4 mg/kg) and DSIP
(100  3 dB, 60 s) at hourly intervals after the injection.
a Comparison of the number of rats convulsing between: A vs. D.
b Comparison of the number of rats convulsing between: mp vs.
c Comparison of the number of rats convulsing between: mp vs.
* Fisher’s exact probability test (P < 0.05).reported a broad array of its physiological effects in
addition to somnogenic action.7—14 Based on struc-
ture—activity relationship studies aimed at improve-
ment of DSIP action, increased stability against
proteolysis and improved lipophilicity, a series of
its analogues were synthesized by replacing amino
acids in position 1, 2 or 6 of the native peptide.7,8
Our study has been conducted on rats expressing
generalized audiogenic reflex epilepsy induced by
the metaphit. The blocking effects of somnogenic
nonapeptide DSIP and its analogue DSIP12 (nona-
peptide with alanine in position 2 of DSIP molecule
substituted by b-alanine) in metaphit-induced epi-
lepsy in rats were studied with an aim of shedding
more light on their mechanism of action and answer-ents and blocking effects of DSIP and DSIP12 in rats.
Tonus
n = 9
(D)
n = 9
(A)
n = 12
(mp)
n = 9
(D)
n = 9
(A)
1
2
3
3
6
7
9
9 9 8 9 9
9 6 7 8 3a,*
8 5 7 7 3
8 6 5 6 2
6 6 7 6 2
7 3 5 6 1a,*
6 3 7 6 2
6 4 5 5 4
6 4 5 4 4
5 3 2 5 2
4 4 4 4 2
1 2 5 1 2
0 1 4 0 1
0 1 2 0 1
0 1 3 0 1
0 1 3 0 1
1 4 0
0 4 0
0 3 0
0 2 0
0 2
3
1
etaphit; D: mp + DSIP; A: mp + DSIP12. The rats treated with
12 (0.4 mg/kg); were exposed to an intense audio stimulation
D.
A.
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used as antiepileptic agents.Table 2 Time course of mean seizure grade.
T (h) n = 12 (mp) n = 9 (D) n = 9 (A)
1 0.33
2 0.58
3 0.92
4 1.00
5 1.83
6 1.92
7 2.25
8 2.00 3.00 3.00
9 1.92 2.89a 1.67
10 2.25 1.67 1.44
11 1.92 2.56a 1.33
12 2.00 2.22 1.44
13 1.58 2.33 0.78
14 1.75 2.11 1.00
15 1.50 1.89 1.33
16 1.42 1.89 1.33
17 1.25 1.89 0.89
18 1.25 1.44 1.11
19 1.50 0.56 0.67
20 1.33 0.22 0.33
21 0.83 0.22 0.44
22 0.92 0.11 0.33
23 0.92 0.00 0.33
24 1.17 0.00 0.22
25 1.08 0.00 0.00
26 0.75 0.00 0.00
27 0.50 0.00 0.00
28 0.50 0.00 0.00
29 0.75 0.00 0.00
30 0.17 0.00 0.00
a Comparison of mean seizure grade between groups: A vs. D
was calculated by Kruskal—Wallis one-way ANOVA and Mann—
Whitney U-test (P < 0.05). For the details see Table 1.Material and methods
All experiments were performed at the Neurophy-
siological Laboratory, Institute of Physiology, School
of Medicine, University of Belgrade.
Adult male Wistar albino rats weighing 180—200 g
(Military Medical Academy Breeding Laboratories,
Belgrade) were used. The animals were maintained
at ambient temperature (21  2 8C and 12/12-h
light/dark cycle with light switched on at
09:00 h). They were housed individually in transpar-
ent plastic cages with food and water ad libitum.
None of the animals screened for audiogenic sus-
ceptibility showed seizure activity. Audiogenic sti-
mulation (AGS) has been applied for 60 s using an
electric bell (on the top of the cage) generating
100  3 dB at frequency of 5—8 kHz. The first sti-
mulation was applied 1 h after metaphit adminis-
tration and repeated afterwards at hourly intervals
during the experiment. Audiogenic convulsive beha-
vior was assessed by incidence of motor seizure and
seizure severity grade, presented (as previously
reported1,2,14) using three-degree descriptive rating
scale (0: no response; 1: wild running; 2: wild run-
ning followed by clonic seizures; 3: wild running
progressing to generalized clonic and then tonic
extension of fore and hind limbs and tail).
The rats were divided into four groups: saline-
injected controls (n = 6); metaphit-administered
(mp: 10 mg/kg; n = 12); metaphit + DSIP (D:
0.4 mg/kg; n = 9) and metaphit + DSIP12 (A:
0.4 mg/kg; n = 9). This time-course study revealed
that the peak of metaphit-induced convulsive activ-
ity (10 mg/kg, i.p.), occurs 8—12 h after the injec-
tion. Metaphit-treated animals displaying seizures
in eight previous tests had received DSIP or its
analogue and afterwards audiogenic stimuli (AGS)
were applied at hourly intervals for next 30 h. The
third and fourth groups consisted of smaller number
of animals than the second group, because all those
animals that did not show peak incidence of meta-
phit-induced epilepsy after eight tests were
excluded. Injection solutions were prepared in ster-
ile physiological saline immediately before admin-
istration. All treatments were performed via i.p.
route employing injection volume of 0.1 ml.
For the EEG recordings three gold-plated screws
were implanted into the skull over frontal, parietal
and occipital cortices. From these bilateral elec-
trode placements, recordings were taken ipsilater-
ally and bilaterally. The rats were anesthetized with
sodium pentobarbital (40 mg/kg, i.p.), positioned ina stereotaxic apparatus and three gold-plated
recording electrodes were implanted over frontal,
parietal and occipital cortices. EEG apparatus
(Alvar, France) with a modified output degree
enabling transfer of output signals to the input
circuit of 8-channel, 12-bit AD card PCL-711B
(Advantech Co. Ltd., Taiwan, ROC) installed into
computer and the corresponding software used.
Length of epochs for EEG analysis was different in
the characteristic EEG changes such as burst of
spike-and-wave complexes, EEG seizure response,
EEG effect of DSIP and were behaviorally character-
ized (i.e. muscle jerk). EEG power spectra were
analyzed by Math Lab v.6.1 mathematical program
(The Mathworks Inc., MA, USA). Such an analysis
provided absolute power (mV2) for a, b1, b2, d and u
EEG frequency bands and for the total (Tot) spectra.
In the present study epochs of 5—45 s were used for
1 h time.
Significance of the differences between experi-
mental groups: metaphit (mp) versus metaphit + D-
244 O.P. Stanojlovic´ et al.SIP (D), mp versus metaphit + DSIP12 (A) and D
versus A, was evaluated using Fisher’s exact prob-
ability test for the data incidence, Kruskal—Wallis
one-way ANOVA and Mann—Whitney U-test for
those in mean seizure grade and Kruskal—Wallis
ANOVA test for the differences in mean duration
of convulsive component. P < 0.05 was considered
significant.
Synthetic DSIP, a nonapeptide with molecular
mass of 849 and the following amino acid sequence:
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, with trypto-
phan at the amino terminal end and glutamic acid
at the carboxyl terminal end, has been used.
DSIP analogue, DSIP12 is a nonapeptide with
alanine in position 2 of DSIP molecule substituted
by b-alanine, (donated by Dr. I.I. Mikhaleva of the
Shemyakin Institute of Bioorganic Chemistry, Russia,
while Dr. M.E.A. Reith, Univ. Illinois, Coll. Med.,Figure 3 Histograms of the duration for the principal phases
(time from onset of sound stimulation to the onset of running)
bar represents the mean  S.E.M. Comparison of the mean d
ANOVA test; mp vs. A (**P < 0.01). The histograms represent
(mp: 10 mg/kg; n = 12); metaphit + DSIP (D: 0.4 mg/kg; n =
columns do not have error bars due to the fact that (1) mean
clonic and tonic component) were observed in only one animPeoria, USA kindly donated Metaphit methanesulfo-
nate, Sigma-Aldrich Chemical Co., USA).Results
In saline-injected control animals, behavior and EEG
tracing showed no signs of convulsive activity in
response to audiogenic stimuli. Metaphit injection
produced the changes in EEG after 0.5—1 h seen as
sporadic isolated waves. EEG and behavioral sei-
zures were elicited by AGS forming a series of
polyspikes, synchronized spikes and fast high-vol-
tage and low frequency activities that represent
typical seizure manifestations. The rats displayed
wild running after a latency period that evolved into
generalized clonic convulsions and the most severe
tonic convulsions when EEG power spectra increasedof audiogenic seizure components. (a) Duration of latency
and running. (b) Duration of clonic and tonic phase. Each
uration of convulsive components done by Kruskal—Wallis
the data in the following groups: metaphit-administered
9) and metaphit + DSIP12 (A: 0.4 mg/kg; n = 9). Certain
values of the duration of some phases (latency, running,
al or (2) certain data had S.E. = 0.
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Fig. 3. (Continued ).and became more intense (Fig. 1). The peak of
metaphit-induced convulsive activity was recorded
8—12 h after the injection judged by the intensity,
high incidence and severity (Fig. 2). Epilepsy
observed in animals abated gradually and disap-
peared 30 h later. About 25% of metaphit-treated
animals (10 mg/kg, i.p.) that never responded to
AGS and behaved normally during this critical time
period were excluded from the experiments.
Incidence of convulsive response in
metaphit + DSIP and metaphit + DSIP12
groups
Only metaphit-injected animals expressing epilepsy
with a maximum incidence and seizure severity
after the 8th AGS received DSIP and its analogue.
Time course studies revealed a mild incidence
reduction of all convulsion components occurring
about 1—5 h after DSIP and DSIP12 injection. After
the appearance of all convulsive components, DSIP
and DSIP12 significantly reduced running activity in
comparison with only metaphit group, at the same
checkpoints: 25 h (P < 0.05) after metaphit admin-istration, DSIP12 expressed more potent blocking
effect in reduction of convulsive responses in com-
parison with DSIP and the difference was statisti-
cally significant (A versus D); for running 10 h
(P < 0.05) and 11 h (P < 0.05) after metaphit
administration; for tonic convulsive responses 9 h
(P < 0.05) and 13 h (P < 0.05) (Table 1). In meta-
phit + DSIP and metaphit + DSIP12 group the mean
seizure grade had most prominent reduction 1 h
(P < 0.05, U = 16.50) and 3 h (P < 0.05, U = 18.00)
after injection of DSIP or its analogue (Table 2).
In addition to the differences in convulsive
response, the groups also differed in duration of
several aspects of seizure components. Mean dura-
tion of tonic component in group A was significantly
reduced 12 h [ F(8.29) = 10.90, P < 0.01] and 13 h
[ F(8.29) = 6.90, P < 0.01], after metaphit injection
in comparison with metaphit group (Fig. 3).
EEG activity characteristic for metaphit epileptic
action (synchronized spikes) was overlapped with
bursts of high amplitude EEG in the 5—10 Hz range (d
and u frequencies). There were increases of the
sequential power spectra particularly in d and u
frequency bands (Fig. 4).
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Figure 4 Different EEG recordings in a metaphit-treated rat (10 mg/kg, i.p.) after DSIP (1 mg/kg, i.p.) administration.
Note high amplitude waves in 5—10 Hz range (d and u) and a very intense power spectrum (mV2/Hz) overlapping a sharp
metaphit-induced spike-wave complex. LF-RP: left fronto-right parietal cortex.Discussion and conclusions
The results of the present study demonstrate that
DSIP and DSIP12 act by increasing the EEG output in
the d range and decreasing the incidence and dura-
tion of convulsive component, as well as mean
seizure grade in metaphit-induced seizures. We
showed previously9 that the dose of 1 mg DSIP/kg
acted by increasing the EEG output in the d range
and significantly elevating the mean power spectra
in comparison with the control group.
Several studies have indicated that DSIP and its
analogues might be representing more than a sleep-
peptide.6,8,10—13 One of them, DSIP12, with an
increased resistance against proteolytic action
and elevated lipophilicity, has been proven to pene-
trate through the blood—brain barrier and to alle-
viate corazole-induced convulsions.8
In forms of acute generalized epilepsy induced by
picrotoxin, corazole,8 bicuculine, thiosemicarba-
zide, strychnine, N-methyl-D-aspartic acid, penty-
lenetetrazole,10,11 and metaphit,2,14 DSIP had
neuroprotective and antiepileptic role. It has been
observed that DSIPand b-endorphin increase seizure
threshold during night period in the pentylene-tet-
razole epilepsy and express neuroprotective
effect.15 A single i.p. DSIP injection acts by prevent-
ing the development of epileptic activity due tocreation of optimal monoamine levels in brain struc-
tures.16 Its effects are manifested via reduction of
excitatory neurotransmitter amino acids (gluta-
mate, aspartate) and at the same time, via dramatic
increase in g-aminobutyric acid and homocarnosine
content.16,17
On the other hand, modulatory effect of DSIP is
manifested through the regulation of the number of
glutamate receptors (NMDA) and limited effect of
this excitatory neuromediator.11 We hypothesized
an existence of a certain unspecific DSIP action on
NMDA receptor complex. It is said that both pre-
synaptic glutamate and Ca2+ influx through postsy-
naptic membrane are decreased while synthetic
rate of NO (a retrograde messenger) is reduced
due to DSIP administration, consequentially leading
to a decline of glutamate release and epileptic
manifestation.18,19
Though sleep and epilepsy have many properties
in common (e.g. spontaneously, recurring event and
EEG hypersynchronization including EEG potentials
that look very similar to epileptiform sharp waves),
sleep is not epilepsy.20 The relationship between
sleep and epilepsy is reciprocal. Rapid eye move-
ment (REM) sleep represents the most antiepileptic
state in the sleep—wake cycle21,22 and deprivation
of REM sleep has been observed to reduce seizure
thresholds.23,24 On the other hand, synchronized
Antiepileptic activity of delta sleep-inducing peptide 247discharge and sleep spindles that characterize slow
wave sleep (SWS) were reported to favor epilepsy.25
Metaphit in a dose of 10 mg/kg i.p. has been
observed to induce audiogenic seizures after sys-
temic and intracerebroventricular administration
and to be truly epileptic in small rodents with
EEG paroxysmal activity and spike-wave com-
plexes.1—5
Our data presented here is in accordance with
the results of Shandra et al.,11 who suggested that
DSIP plays a neuroprotective role against excitatory
N-methyl-D-aspartic acid which shares the same
receptor with metaphit, although they bind to dif-
ferent binding sites. Earlier available data and our
results support the idea that DSIP could represent
one of the factors of the endogenous stabilization
of brain excitability. Structural DSIP’s analogue,
DSIP12, under identical experimental conditions
acted as more potent antiepileptic in generalized
metaphit-induced convulsive activity. All aforemen-
tioned data,8,11,17 together with our results demon-
strating higher efficiency of DSIP12 in comparison
with DSIP supports the idea that DSIP12 may be
considered to have antiepileptic action.Acknowledgements
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